Abstract
In February 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) launched consultations on the reclassification of two progestogen-only contraceptive pills — Lovima 75 microgram film-coated tablets and Hana 75 microgram film-coated tablets — from prescription-only medicines (POMs) to pharmacy (P) medicines. If approved, this will be the first time the contraceptive pill has been […]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
